Self-Assembling Benzothiazole-Based Gelators: A Mechanistic Understanding of in Vitro Bioactivation and Gelation.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Molecular Pharmaceutics

• Publication date

  2018-03-05

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acs.molpharmaceut.7b01106PMID 29502421
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antitumour benzothiazoles. Part 32: DNA adducts and double strand breaks correlate with activity; synthesis of 5F203 hydrogels for local delivery.

  2015cited by this paper
• Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials

  2015cited by this paper
• A supramolecular topical gel derived from a non-steroidal anti-inflammatory drug, fenoprofen, is capable of treating skin inflammation in mice.

  2015cited by this paper
• Insights into low molecular mass organic gelators: a focus on drug delivery and tissue engineering applications.

  2014cited by this paper
• The development of low-molecular weight hydrogels for applications in cancer therapy.

  2014cited by this paper
• (-)-Menthol based thixotropic hydrogel and its application as a universal antibacterial carrier.

  2014cited by this paper
• Short to ultrashort peptide hydrogels for biomedical uses

  2014cited by this paper
• Nanostructures and self-assembly of organogels via benzimidazole/benzothiazole imide derivatives with different alkyl substituent chains

  2013cited by this paper
• Biomarkers of sensitivity to potent and selective antitumor 2‐(4‐amino‐3‐methylphenyl)‐5‐fluorobenzothiazole (5F203) in ovarian cancer

  2013cited by this paper
• Prodrugs as self-assembled hydrogels: a new paradigm for biomaterials.

  2013cited by this paper
• Self-assembly and soft material preparation of binary organogels via aminobenzimidazole/benzothiazole and acids with different alkyl substituent chains

  2013cited by this paper
• Fmoc-diphenylalanine hydrogels: understanding the variability in reported mechanical properties.

  2012cited by this paper
• Molecular hydrogelators consist of Taxol and short peptides/amino acids

  2012cited by this paper
• Folic acid as a versatile motif to construct molecular hydrogelators through conjugations with hydrophobic therapeutic agents

  2012cited by this paper
• Bioactivation of fluorinated 2-aryl-benzothiazole antitumor molecules by human cytochrome P450s 1A1 and 2W1 and deactivation by cytochrome P450 2S1.

  2012cited by this paper
• CYP2S1 and CYP2W1 Mediate 2-(3,4-Dimethoxyphenyl)-5-Fluorobenzothiazole (GW-610, NSC 721648) Sensitivity in Breast and Colorectal Cancer Cells

  2011cited by this paper
• Phortress: the smart antitumour agent which induces its own metabolism

  2010cited by this paper
• A new method for maintaining homogeneity during liquid–hydrogel transitions using low molecular weight hydrogelators

  2009cited by this paper
• 2-(4-Amino-3-methylphenyl)-5-fluorobenzothiazole is a ligand and shows species-specific partial agonism of the aryl hydrocarbon receptor.

  2009cited by this paper
• Enzyme-instructed molecular self-assembly confers nanofibers and a supramolecular hydrogel of taxol derivative.

  2009cited by this paper
• Self-assembled prodrugs: an enzymatically triggered drug-delivery platform.

  2009cited by this paper
• Preclinical Toxicokinetic Evaluation of Phortress [2-(4-Amino-3-Methylphenyl)-5-Fluorobenzothiazole Lysylamide Dihydrochloride] in Two Rodent Species

  2008cited by this paper
• Prodrugs: design and clinical applications

  2008cited by this paper
• Prodrugs for Amines

  2008cited by this paper
• New dicholesteryl-based gelators: gelling ability and selective gelation of organic solvents from their mixtures with water at room temperature

  2008cited by this paper
• The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate.

  2004cited by this paper
• Preclinical evaluation of amino acid prodrugs of novel antitumor 2-(4-amino-3-methylphenyl)benzothiazoles.

  2002cited by this paper
• Antitumor benzothiazoles. 16. Synthesis and pharmaceutical properties of antitumor 2-(4-aminophenyl)benzothiazole amino acid prodrugs.

  2002cited by this paper
• Antitumor benzothiazoles. 14. Synthesis and in vitro biological properties of fluorinated 2-(4-aminophenyl)benzothiazoles.

  2001cited by this paper
• (Acyloxy)alkyl carbamates as novel bioreversible prodrugs for amines: increased permeation through biological membranes.

  1988cited by this paper
• N-(acyloxyalkoxycarbonyl) derivatives as potential prodrugs of amines. I: Kinetics and mechanism of degradation in aqueous solutions

  1987cited by this paper

• L-Cysteine/AgNO2 low molecular weight gelators: self-assembly and suppression of MCF-7 breast cancer cells.

  2020cites this paper
• Dietary natural flavonoids treating cancer by targeting aryl hydrocarbon receptor

  2019cites this paper
• Title Dietary natural flavonoids treating cancer by targeting aryl hydrocarbon receptor

  2019cites this paper